category,datetime,headline,id,image,related,source,summary,url
company,1769090400,Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products,138204726,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,COR,Yahoo,"ATLANTA, January 22, 2026--Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with an integrated solution to support the commercialization of their products.",https://finnhub.io/api/news?id=3ae90b78c69847e375f75e2d2ef0269fb130e22b20747643144565b1edc4a4aa
company,1769085000,Cencora Elects Ellen Cooper to Its Board of Directors,138203940,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,COR,Yahoo,"CONSHOHOCKEN, Pa., January 22, 2026--Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Ellen Cooper as a new independent director, effective January 20, 2026.",https://finnhub.io/api/news?id=b859c997be3ec17ddf0296ff8c4080df741e6e4faba3972b8ee9467215dafac1
